Talis Biomedical (TLIS)
OTHER OTC:TLIS
US Market
Holding TLIS?
Track your performance easily

Talis Biomedical (TLIS) Financial Statements

43 Followers

Talis Biomedical Financial Overview

Talis Biomedical's market cap is currently ―. The company's EPS TTM is $-28.018; its P/E ratio is -0.07; Talis Biomedical is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-$ 73.00K$ 76.00K--
Gross Profit-$ 67.00K$ 70.00K$ -7.00K$ -20.00K
EBIT$ -8.85M$ -13.04M$ -16.97M$ -15.03M$ -17.83M
EBITDA$ -8.77M$ -12.77M$ -16.75M$ -14.87M$ -17.66M
Net Income Common Stockholders$ -8.85M$ -13.04M$ -15.68M$ -15.03M$ -17.83M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 59.87M$ 70.34M$ 88.00M$ 99.21M$ 113.97M
Total Assets$ 72.70M$ 82.49M$ 107.23M$ 123.08M$ 133.05M
Total Debt$ 18.80M$ 19.24M$ 20.08M$ 20.38M$ 14.71M
Net Debt$ -41.07M$ -51.10M$ -67.91M$ -78.83M$ -99.26M
Total Liabilities$ 24.07M$ 25.81M$ 25.67M$ 26.91M$ 22.93M
Stockholders Equity$ 48.63M$ 56.68M$ 81.56M$ 96.17M$ 110.12M
Cash Flow-
Free Cash Flow$ -11.25M$ -6.40M$ -11.21M$ -14.76M$ -16.49M
Operating Cash Flow$ -11.33M$ -6.43M$ -11.14M$ -14.27M$ -16.46M
Investing Cash Flow$ 84.00K$ 30.00K$ -70.00K$ -485.00K$ -24.00K
Financing Cash Flow-$ 2.00K--$ 33.00K
Currency in USD

Talis Biomedical Earnings and Revenue History

Talis Biomedical Debt to Assets

Talis Biomedical Cash Flow

Talis Biomedical Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis